Nasdaq
MOLN
Molecular Partners AG
- Health Care
- Switzerland
- Listed 2021
- 1 day
- −2.6%
- 1 month
- −1.0%
- 1 year
- +16.4%
$4.05 · Mkt cap $163M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Molecular Partners AG
$4.05 · Mkt cap $163M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Molecular Partners AG trades under the ticker MOLN on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2021. Its market capitalisation is $163M. The last closing price was $4.05, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +16.4%, and −1.0% over the past month. Returns are price returns and exclude dividends.
This page exists because MOLN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.